Numis Securities reaffirmed their hold rating on shares of Victrex (LON:VCT) in a report published on Monday, Digital Look reports. They currently have a GBX 2,350 ($30.71) price target on the stock, down from their prior price target of GBX 2,550 ($33.32).
Several other equities analysts have also recently issued reports on the stock. Peel Hunt reaffirmed an add rating and issued a GBX 2,500 ($32.67) price objective (down previously from GBX 2,850 ($37.24)) on shares of Victrex in a research note on Wednesday, February 6th. Liberum Capital reaffirmed a buy rating on shares of Victrex in a research note on Tuesday, February 5th. Berenberg Bank lowered their price objective on shares of Victrex from GBX 2,600 ($33.97) to GBX 2,550 ($33.32) and set a hold rating on the stock in a research note on Thursday, February 7th. JPMorgan Chase & Co. reaffirmed a neutral rating on shares of Victrex in a research note on Friday, February 1st. Finally, Barclays reaffirmed an underweight rating and issued a GBX 2,210 ($28.88) price objective (down previously from GBX 2,420 ($31.62)) on shares of Victrex in a research note on Friday, March 29th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and a consensus target price of GBX 2,395 ($31.29).
VCT stock opened at GBX 2,052 ($26.81) on Monday. Victrex has a 52 week low of GBX 2,014.55 ($26.32) and a 52 week high of GBX 3,434 ($44.87). The stock has a market cap of $1.78 billion and a price-to-earnings ratio of 17.84.
In other Victrex news, insider Jakob Sigurdsson acquired 3,000 shares of the stock in a transaction dated Tuesday, May 14th. The shares were bought at an average price of GBX 2,092 ($27.34) per share, with a total value of £62,760 ($82,007.06). Insiders bought a total of 6,010 shares of company stock worth $13,544,820 in the last ninety days.
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers.
Featured Story: What is the NASDAQ?
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.